Abstract
Immunological and inflammatory reactions play a pivotal role in the initiation and perpetuation of rheumatoid arthritis. The present study is an attempt to estimate the levels of adenosine deaminase (ADA) activity, a marker for cell mediated immunity and C-reactive protein a marker for inflammation in patients with rheumatoid arthritis.75 cases presenting rheumatoid arthritis and same number of age and sex matched healthy controls were included in the study. Serum ADA activity was measured spectrophotometrically at 630 nm and serum C-reactive protein was detected using Avitex CRP kit, which is a rapid latex agglutination test. The mean ADA levels were 59.79 ± 21.09 in patients and 20.71 ± 5.63 in controls, significant at p< 0.01. CRP test was found to be positive in 69/75 cases of RA and none of the controls. The present study observed the importance of ADA as a serum marker in addition to CRP for better therapeutic management of RA.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
